Curative treatment of oesophageal carcinoma: current options and future developments

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Wolf, Maria C ^a   Stahl, Michael ^b   Krause, Bernd J ^c,d   Bonavina, Luigi ^e   Bruns, Christiane ^a   Belka, Claus ^a   Zehentmayr, Franz ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE PERIOD; PROGNOSIS; SALVAGE THERAPY; TREATMENT RESPONSE; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79957441529     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-55     Document Type: Article

References (54)

1. Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 2002, 16(2):263-266. 10.1007/s00464-001-8161-3, 11967675.
2. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, Schoenberg J, Greenberg R, Liff J, Schwartz A, et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001, 153(2):114-122. 10.1093/aje/153.2.114, 11159155.
3. Fukuzawa K, Noguchi Y, Yoshikawa T, Saito A, Doi C, Makino T, Takanashi Y, Ito T, Tsuburaya A. High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract. Cancer Lett 1999, 144(2):145-151. 10.1016/S0304-3835(99)00223-2, 10529014.
4. Bonavina L, Incarbone R, Saino G, Clesi P, Peracchia A. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus 2003, 16(2):90-93. 10.1046/j.1442-2050.2003.00300.x, 12823204.
5. Siewert JR, Feith M, Stein HJ. Esophagectomy as therapeutic principle for squamous cell esophageal cancer. Chirurg 2005, 76(11):1033-1043. 10.1007/s00104-005-1096-9, 16228234.
6. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001, 234(3):360-367. discussion 368-369, 10.1097/00000658-200109000-00010, 1422027, 11524589.
7. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005, 242(4):566-573. discussion 573-565, 1402356, 16192817.
8. Chang CCDT, Shen J, Su Z, Koong AC. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. Am J Clin Oncol 2009, 32(4):405-410. 10.1097/COC.0b013e3181917158, 19415029.
9. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998, 85(6):840-844. 10.1046/j.1365-2168.1998.00663.x, 9667720.
10. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347(21):1662-1669. 10.1056/NEJMoa022343, 12444180.
11. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246(6):992-1000. discussion 1000-1001, 10.1097/SLA.0b013e31815c4037, 18043101.
12. Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, et al. Surgical treatment for esophageal cancer. Current issues. Dig Surg 2007, 24(2):88-95. 10.1159/000101894, 17446703.
13. Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998, 175(1):47-51. 10.1016/S0002-9610(97)00227-4, 9445239.
14. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 2001, 234(5):581-587. 10.1097/00000658-200111000-00001, 1422081, 11685019.
15. Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001, 72(1):306-313. 10.1016/S0003-4975(00)02570-4, 11465217.
16. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349(22):2117-2127. 10.1056/NEJMsa035205, 14645640.
17. Orringer MB, Sloan H. Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg 1978, 76(5):643-654.
18. Buess G, Naruhn M, Motzung T, Mentges B, Becker HD. Training program for minimally invasive surgery. Chirurg 1991, 62(4):276-283.
19. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992, 37(1):7-11.
20. Bonavina L, Incarbone R, Lattuada E, Segalin A, Cesana B, Peracchia A. Preoperative laparoscopy in management of patients with carcinoma of the esophagus and of the esophagogastric junction. J Surg Oncol 1997, 65(3):171-174. 10.1002/(SICI)1096-9098(199707)65:3<171::AID-JSO5>3.0.CO;2-3, 9236925.
21. DePaula AL, Hashiba K, Ferreira EA, de Paula RA, Grecco E. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 1995, 5(1):1-5.
22. Bonavina L, Incarbone R, Bona D, Peracchia A. Esophagectomy via laparoscopy and transmediastinal endodissection. J Laparoendosc Adv Surg Tech A 2004, 14(1):13-16. 10.1089/109264204322862298, 15035838.
23. Bonavina L, Bona D, Binyom PR, Peracchia A. A laparoscopy-assisted surgical approach to esophageal carcinoma. J Surg Res 2004, 117(1):52-57. 10.1016/j.jss.2003.11.007, 15013714.
24. Biere SS, Maas KW, Bonavina L, Roig Garcia J, van Berge Henegouwen MI, Rosman C, Sosef MN, de Lange ES, Bonjer HJ, Cuesta MA, et al. Traditional invasive vs. minimally invasive esophagectomy: a multi-centered, randomized trial (TIME-trial). BMC Surg 2011, 11(1):2. 10.1186/1471-2482-11-2, 3031195, 21226918.
25. Bonavina L. Selected commentary to "Fifty-five minimally invasive esophagectomies: a single center experience". Eur Surg 2009, 41(4):194-198.
26. Palanivelu C, Prakash A, Senthilkumar R, Senthilnathan P, Parthasarathi R, Rajan PS, Venkatachlam S. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position--experience of 130 patients. J Am Coll Surg 2006, 203(1):7-16. 10.1016/j.jamcollsurg.2006.03.016, 16798482.
27. Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003, 238(4):486-494. discussion 494-485, 1360107, 14530720.
28. Taguchi S, Osugi H, Higashino M, Tokuhara T, Takada N, Takemura M, Lee S, Kinoshita H. Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc 2003, 17(9):1445-1450. 10.1007/s00464-002-9232-9, 12811660.
29. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998, 339(27):1979-1984. 10.1056/NEJM199812313392704, 9869669.
30. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005, 137(2):172-177. 10.1016/j.surg.2004.06.033, 15674197.
31. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007, 8(3):226-234. 10.1016/S1470-2045(07)70039-6, 17329193.
32. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185(6):538-543. 10.1016/S0002-9610(03)00066-7, 12781882.
33. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003, 10(7):754-761. 10.1245/ASO.2003.03.078, 12900366.
34. Malthaner RA, Wong RK, Rumble RB, Zuraw L. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC medicine 2004, 2:35. 10.1186/1741-7015-2-35, 529457, 15447788.
35. Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, Falchi AM, Craxi A, Camma C. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004, 53(7):925-930. 10.1136/gut.2003.025080, 1774092, 15194636.
36. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326(24):1593-1598. 10.1056/NEJM199206113262403, 1584260.
37. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999, 281(17):1623-1627. 10.1001/jama.281.17.1623, 10235156.
38. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2006, (1):CD002092.
39. Chiu PW, Chan AC, Leung SF, Leong HT, Kwong KH, Li MK, Au-Yeung AC, Chung SC, Ng EK. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005, 9(6):794-802. 10.1016/j.gassur.2005.05.005, 16187480.
40. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20(5):1167-1174. 10.1200/JCO.20.5.1167, 11870157.
41. Berger B, Belka C. Evidence-based radiation oncology: oesophagus. Radiother Oncol 2009, 92(2):276-290. 10.1016/j.radonc.2009.02.019, 19375187.
42. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335(7):462-467. 10.1056/NEJM199608153350702, 8672151.
43. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008, 26(7):1086-1092. 10.1200/JCO.2007.12.9593, 18309943.
44. Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B, Nygaard K, Parmar MK, Roussel A, Spiliopoulos G, et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998, 41(3):579-583. 10.1016/S0360-3016(97)00569-5, 9635705.
45. Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005, 23(19):4330-4337. 10.1200/JCO.2005.05.017, 15781882.
46. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005, 6(9):659-668. 10.1016/S1470-2045(05)70288-6, 16129366.
47. Stuschke M, Sarbia M. Neoadjuvante Radiochemotherapie und Responseprädiktion. Onkologe 2004, 10:1179-1190.
48. Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007, 25(10):1160-1168. 10.1200/JCO.2005.04.7118, 17401004.
49. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005, 23(10):2310-2317. 10.1200/JCO.2005.00.034, 15800321.
50. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007, 8(6):545-553. 10.1016/S1470-2045(07)70172-9, 17540306.
51. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008, 98(3):547-557. 10.1038/sj.bjc.6604200, 2243147, 18212745.
52. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008, 49(3):480-508. 10.2967/jnumed.107.047787, 18287273.
53. Krause BJ, Herrmann K, Wieder H, zum Buschenfelde CM. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer. J Nucl Med 2009, 50(Suppl 1):89S-96S.
54. Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, Lorenzen S, Schuster T, Wieder H, Herrmann K, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007, 8(9):797-805. 10.1016/S1470-2045(07)70244-9, 17693134.